Induction of ovarian cancer by defined multiple genetic changes in a mouse model system

Cancer Cell

Volumn 1, Issue 1, 2002, Pages 53-62

  Orsulic, Sandra ^a   Li, Yi ^a   Soslow, Robert A ^a   Vitale Cross, Lynn A ^b   Gutkind, J Silvio ^b   Varmus, Harold E ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE B; PROTEIN P53; RETROVIRUS VECTOR; ACTIN; AKT1 PROTEIN, HUMAN; ALKALINE PHOSPHATASE; AVIAN PROTEIN; CALCIUM BINDING PROTEIN; ONCOPROTEIN; PROTEIN SERINE THREONINE KINASE; TVA RECEPTOR; VIRUS RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GENETICS; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; EPITHELIUM; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENE SEQUENCE; GENETIC CODE; GENETIC ENGINEERING; METASTASIS; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE C MYC; ONCOGENE K RAS; OVARY CANCER; OVARY CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; TRANSGENIC MOUSE; VIRAL GENE DELIVERY SYSTEM; ANIMAL; CARCINOMA; CELL DIVISION; CELL TRANSFORMATION; DISEASE MODEL; ENZYME IMMUNOASSAY; GENE TRANSFER; GENE VECTOR; GENETICS; HUMAN; METABOLISM; MOUSE MUTANT; ONCOGENE MYC; ONCOGENE RAS; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; WESTERN BLOTTING;

AVES; MUS MUSCULUS;

ACTINS; ALKALINE PHOSPHATASE; ANIMALS; AVIAN PROTEINS; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CARCINOMA; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; FEMALE; GENE TRANSFER TECHNIQUES; GENES, MYC; GENES, RAS; GENETIC VECTORS; HUMANS; IMMUNOENZYME TECHNIQUES; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; OVARIAN NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, VIRUS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036463949     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(01)00002-2     Document Type: Article

References (45)

1. Adams, A.T., and Auersperg, N. (1981). Transformation of cultured rat ovarian surface epithelial cells by Kirsten murine sarcoma virus. Cancer Res. 41, 2063-2072.
2. Auersperg, N., Wong, A.S., Choi, K.C., Kang, S.K., and Leung, P.C. (2001). Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr. Rev. 22, 255-288.
3. Aunoble, B., Sanches, R., Didier, E., and Bignon, Y.J. (2000). Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review). Int. J. Oncol. 16, 567-576.
4. Baker, V.V., Borst, M.P., Dixon, D., Hatch, K.D., Shingleton, H.M., and Miller, D. (1990). c-myc amplification in ovarian cancer. Gynecol. Oncol. 38, 340-342.
5. Bates, P., Young, J.A., and Varmus, H.E. (1993). A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor. Cell 74, 1043-1051.
6. Bell, D.A., and Scully, R.E. (1994). Early de novo ovarian carcinoma. A study of fourteen cases. Cancer 73, 1859-1864.
7. Bellacosa, A., de Feo, D., Godwin, A.K., Bell, D.W., Cheng, J.Q., Altomare, D.A., Wan, M., Dubeau, L., Scambia, G., and Masciullo, V. (1995). Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int. J. Cancer 64, 280-285.
8. Berchuck, A., and Carney, M. (1997). Human ovarian cancer of the surface epithelium. Biochem. Pharmacol. 54, 541-544.
9. Brulet, P., Babinet, C., Kemler, R., and Jacob, F. (1980). Monoclonal antibodies against trophectoderm-specific markers during mouse blastocyst formation. Proc. Natl. Acad. Sci. USA 77, 4113-4117.
10. Caduff, R.F., Svoboda-Newman, S.M., Ferguson, A.W., Johnston, C.M., and Frank, T.S. (1999). Comparison of mutations of Ki-RAS and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors. Am. J. Surg. Pathol. 23, 323-328.
11. Cheng, J.Q., Godwin, A.K., Bellacosa, A., Taguchi, T., Franke, T.F., Hamilton, T.C., Tsichlis, P.N., and Testa, J.R. (1992). AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Proc. Natl. Acad. Sci. USA 89, 9267-9271.
12. Cuatrecasas, M., Villanueva, A., Matias-Guiu, X., and Prat, J. (1997). K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases. Cancer 79, 1581-1586.
13. Doetsch, F., Caille, I., Lim, D.A., Garcia-Verdugo, J.M., and Alvarez-Buylla, A. (1999). Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 97, 703-716.
14. Dokianakis, D.N., Varras, M.N., Papaefthimiou, M., Apostolopoulou, J., Simiakaki, H., Diakomanolis, E., and Spandidos, D.A. (1999). Ras gene activation in malignant cells of human ovarian carcinoma peritoneal fluids. Clin. Exp. Metastasis 17, 293-297.
15. Dubeau, L. (1999). The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes? Gynecol. Oncol. 72, 437-442.
16. Federspiel, M.J., Bates, P., Young, J.A., Varmus, H.E., and Hughes, S.H. (1994). A system for tissue-specific gene targeting: transgenic mice susceptible to subgroup A avian leukosis virus-based retroviral vectors. Proc. Natl. Acad. Sci. USA 91, 11241-11245.
17. Federspiel, M.J., Swing, D.A., Eagleson, B., Reid, S.W., and Hughes, S.H. (1996). Expression of transduced genes in mice generated by infecting blastocysts with avian leukosis virus-based retroviral vectors. Proc. Natl. Acad. Sci. USA 93, 4931-4936.
18. Feeley, K.M., and Wells, M. (2001). Precursor lesions of ovarian epithelial malignancy. Histopathology 38, 87-95.
19. Fisher, G.H., Orsulic, S., Holland, E., Hively, W.P., Li, Y., Lewis, B.C., Williams, B.O., and Varmus, H.E. (1999). Development of a flexible and specific gene delivery system for production of murine tumor models. Oncogene 78, 5253-5260.
20. Gallion, H.H., Pieretti, M., DePriest, P.D., and van Nagell, J.R. (1995). The molecular basis of ovarian cancer. Cancer 76, 1992-1997.
21. Greenlee, R.T., Murray, T., Bolden, S., and Wingo, P.A. (2000). Cancer statistics, 2000. CA Cancer J. Clin. 50, 7-33.
22. Himly, M., Foster, D.N., Bottoli, I., lacovoni, J.S., and Vogt, P.K. (1998). The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses. Virology 248, 295-304.
23. Holland, E.C., and Varmus, H.E. (1998). Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice. Proc. Natl. Acad. Sci. USA 95, 1218-1223.
24. Holland, E.C., Hively, W.P., DePinho, R.A., and Varmus, H.E. (1998). A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. Genes Dev. 12, 3675-3685.
25. Holland, E.C., Celestino, J., Dai, C., Schaefer, L., Sawaya, R.E., and Fuller, G.N. (2000). Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat. Genet. 25, 55-57.
26. Holschneider, C.H., and Berek, J.S. (2000). Ovarian cancer: epidemiology, biology, and prognostic factors. Semin. Surg. Oncol. 19, 3-10.
27. Hughes, S.H., Greenhouse, J.J., Petropoulos, C.J., and Sutrave, P. (1987). Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors. J. Virol. 61, 3004-3012.
28. Jacks, T., Remington, L., Williams, B.O., Schmitt, E.M., Halachmi, S., Bronson, R.T., and Weinberg, R.A. (1994). Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4, 1-7.
29. Johnson, L., Mercer, K., Greenbaum, D., Bronson, R.T., Crowley, D., Tuveson, D.A., and Jacks, T. (2001). Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 470, 1111-1116.
30. Kido, M., and Shibuya, M. (1998). Isolation and characterization of mouse ovarian surface epithelial cell lines. Pathol. Res. Pract. 194, 725-730.
31. Lynch, H.T., Casey, M.J., Lynch, J., White, T.E., and Godwin, A.K. (1998). Genetics and ovarian carcinoma. Semin. Oncol. 25, 265-280.
32. Mok, S.C., Bell, D.A., Knapp, R.C., Fishbaugh, P.M., Welch, W.R., Muto, M.G., Berkowitz, R.S., and Tsao, S.W. (1993). Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res. 53, 1489-1492.
33. Morita, K., Ono, Y., Fukui, H., Tomita, S., Ueda, Y., Terano, A., and Fujimori, T. (2000). Incidence of P53 and K-ras alterations in ovarian mucinous and serous tumors. Pathol. Int. 50, 219-223.
34. Murphy, G.J., and Leavitt, A.D. (1999). A model for studying megakaryocyte development and biology. Proc. Natl. Acad. Sci. USA 96, 3065-3070.
35. Ramirez, A., Bravo, A., Jorcano, J.L., and Vidai, M. (1994). Sequences 5′ of the bovine keratin 5 gene direct tissue- and cell-type-specific expression of a lacZ gene in the adult and during development. Differentiation 58, 53-64.
36. Roby, K.F., Taylor, C.C., Sweetwood, J.P., Cheng, Y., Pace, J.L., Tawfik, O., Persons, D.L., Smith, P.G., and Terranova, P.F. (2000). Development of a syngeneic mouse model for events related to ovarian cancer. Carcinogenesis 27, 585-591.
37. Schaefer-Klein, J., Givol, I., Barsov, E.V., Whitcomb, J.M., VanBrocklin, M., Foster, D.N., Federspiel, M.J., and Hughes, S.H. (1998). The EV-O-derived cell line DF-1 supports the efficient replication of avian leukosis-sarcoma viruses and vectors. Virology 248, 305-311.
38. Shankaran, V., Ikeda, H., Bruce, A.T., White, J.M., Swanson, P.E., Old, L.J., and Schreiber, R.D. (2001). IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 470, 1107-1111.
39. Shayesteh, L., Lu, Y., Kuo, W.L., Baldocchi, R., Godfrey, T., Collins, C., Pinkel, D., Powell, B., Mills, G.B., and Gray, J.W. (1999). PIK3CA is implicated as an oncogene in ovarian cancer. Nat. Genet. 27, 99-102.
40. Sun, M., Wang, G., Paciga, J.E., Feldman, R.I., Yuan, Z.Q., Ma, X.L., Shelley, S.A., Jove, R., Tsichlis, P.N., Nicosia, S.V., and Cheng, J.Q. (2001). AKT1/ PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am. J. Pathol. 759, 431-437.
41. Suzuki, M., Saito, S., Saga, Y., Ohwada, M., and Sato, I. (2000). Mutation of K-RAS protooncogene and loss of heterozygosity on 6q27 in serous and mucinous ovarian carcinomas. Cancer Genet. Cytogenet. 118, 132-135.
42. Teneriello, M.G., Ebina, M., Linnoila, R.I., Henry, M., Nash, J.D., Park, R.C., and Birrer, M.J. (1993). p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Cancer Res. 53, 3103-3108.
43. Wang, Z.R., Liu, W., Smith, S.T., Parrish, R.S., and Young, S.R. (1999). c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH. Exp. Mol. Pathol. 66, 140-148.
44. Young, J.A., Bates, P., and Varmus, H.E. (1993). Isolation of a chicken gene that confers susceptibility to infection by subgroup A avian leukosis and sarcoma viruses. J. Virol. 67, 1811-1816.
45. Yuan, Z.Q., Sun, M., Feldman, R.I., Wang, G., Ma, X., Jiang, C., Coppola, D., Nicosia, S.V., and Cheng, J.Q. (2000). Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer. Oncogene 19, 2324-2330.